Gainesborough Investment Partners

investment firm

About

London Capital Investment Partners's Gainsborough partnership invests in companies quoted on AIM and Plus markets.

Details

Operating Status
Active
Investor Type
MVC,Venture Capital

London Capital Investment Partners's Gainsborough partnership invests in companies quoted on AIM and Plus markets. The partnership will develop a portfolio of approximately 20 companies. Gainsborough will allocate 20% of its funds to approximately 10 "Earlier Companies" and 80% of its assets to approximately 10 Later Companies. This defensive asset allocation profile will give partners exposure to exciting younger companies, while giving the portfolio a base of more developed companies.

To date the partnership has invested in the following companies:

* Plastics Capital plc (http://www.plasticscapital.com/)
* Surface Transforms plc (http://www.surface-transforms.com/)
* Immunodiagnostic Systems Holdings plc (http://www.idsltd.com)
* BrainJuicer Group plc (www.brainjuicer.com)
* Scancell Holdings plc (www.scancell.co.uk)

Investments

Number of Investments
Number of Lead Investments
5
0
Gainesborough Investment Partners has made 5 investments. Their most recent investment was on May 1, 2008, when OmniGuide raised $25M.
Date Company Name
Round Money Raised Industry Lead Investor
May 1, 2008 OmniGuide
Series E $25M Health Care
Series C $17.50M Manufacturing
Series Unknown $6M Biopharma
Oct 12, 2001 Cetek Corporation
Series Unknown $14M Biopharma
Series A $1M Manufacturing

Exits

Gainesborough Investment Partners has had 1 exits. Gainesborough Investment Partners most notable exits include Continuum Photonics

Date Company Name Exit Type Industry
Sep 26, 2005 Continuum Photonics M&A Manufacturing Detail